Related Experiment Video
Updated: Aug 10, 2026
Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
[Detection, quantification and characterization of disseminated tumor cells]
P F Ambros1, G Méhes, Inge M Ambros
1Children's Cancer Research Institute (CCRI), St. Anna Kinderspital, Kinderspitalgasse 6, A-1090 Wien. ambros@ccri.univie.ac.at
Detecting disseminated tumor cells (DTCs) in the bloodstream is crucial for predicting metastasis and monitoring cancer treatment effectiveness. Accurate identification of DTCs is essential for reliable bone marrow diagnostics and understanding tumor biology.
Area of Science:
- Oncology
- Hematology
- Cell Biology
Context:
- Disseminated tumor cells (DTCs) in the hematopoietic system offer insights into tumor metastasis and treatment response.
- Early-stage DTCs are implicated in the development of metastases in various cancers.
- Quantifying DTCs provides a method to monitor disease progression and therapeutic efficacy.
Purpose:
- To highlight the significance of detecting DTCs in the hematopoietic system.
- To underscore the role of DTCs in predicting metastatic potential and patient outcomes.
- To emphasize the importance of accurate DTC identification for effective cancer management.
Summary:
- Detection of DTCs in the hematopoietic system is vital for assessing metastatic potential and treatment response.
- Studies correlate DTC presence with unfavorable outcomes in epithelial and embryonic tumors.
- DTC quantification allows for monitoring therapy effects and understanding tumor cell biology.
Impact:
- Accurate DTC detection aids in early metastasis prediction.
- Monitoring DTCs can guide treatment decisions and personalize therapy.
- Improved diagnostic systems for DTCs minimize false positives in bone marrow analysis.
More Related Videos
05:17Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
Published on: May 14, 2019
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019